Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.53 | N/A |
| PEG Ratio (TTM) | -0.60 | N/A |
| P/S Ratio (TTM) | 0.84 | N/A |
| P/B Ratio (TTM) | 1.69 | N/A |
| P/FCF Ratio (TTM) | 4.14 | N/A |
| Price to 5YR AVG Earnings Ratio | 2.94 | N/A |
| Price to 5YR AVG FCF Ratio | 5.54 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.42% | N/A |
| ROE (TTM) | 16.18% | N/A |
| Net Profit Margin (TTM) | 8.81% | N/A |
| ROIC 5YR AVG | 2.96% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.93% | 156.28% | 80.76% |
| Revenue | 1.97% | -22.01% | 8.02% |
| Net Income | -2.60% | 158.78% | 84.08% |
| Cash Flow | 29.53% | -43.88% | 333.46% |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.10 | N/A |
| Quick Ratio (TTM) | 0.10 | N/A |
| D/E Ratio (TTM) | 0.53 | N/A |
| Interest Coverage (TTM) | 2.07 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.09 | N/A |
| LTL to 5YR AVG FCF | 2.94 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.17% | N/A |